ORTHOKERATOLOGY MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America dominates the global orthokeratology market with an estimated market share of 41.3% in 2024. The region boasts strong presence of leading industry players with established manufacturing and R&D facilities. Major players such as Johnson & Johnson Vision and Bausch & Lomb have their headquarters located in the U.S., allowing them to cater to local demand efficiently. Favorable reimbursement policies for medical devices and eye care products contribute to higher product adoption. Patients in the U.S. and Canada are quick to adopt the latest technologies and orthokeratology is gaining popularity as a non-invasive option for vision correction.

Asia Pacific has emerged as the fastest growing regional market for orthokeratology. China, in particular, plays a key role in driving the market growth in the region. The staggering population, rising disposable income, and growing focus on ophthalmic treatments boosts demand from countries such as China and India. The availability of cheaper alternatives compared to refractive surgeries prmpt many individuals to opt for the orthokeratology treatment method. Local manufacturers are strengthening their position by offering products at competitive prices. This has boosted the affordability of orthokeratology devices and accelerated the penetration of branded products as well. Furthermore, increasing medical tourism and high incidence of myopia among students in countries like China and South Korea are boosting adoption. Countries in Southeast Asia are also expected to contribute significantly to the market expansion in Asia Pacific.